Modified Blalock Taussig shunt: a not-so-simple palliative procedure

Area of Science:

• Pediatric Cardiac Surgery
• Congenital Heart Disease
• Palliative Procedures

Background:

• The modified Blalock-Taussig (BT) shunt is a palliative procedure for complex congenital heart defects.
• Despite advancements in primary corrective surgeries, shunt palliation remains relevant for specific infant cardiac conditions.

Purpose of the Study:

• To analyze risk factors for shunt intervention and mortality in infants undergoing isolated modified BT shunts.
• To evaluate the outcomes of modified BT shunt palliation in a cohort of infants.

Main Methods:

• Retrospective review of 32 consecutive isolated modified BT shunts performed since 2004.
• Analysis of patient demographics, shunt characteristics, and clinical outcomes including mortality and morbidity.
• Exclusion of hypoplastic left heart syndrome patients; sternotomy as the sole surgical approach.

Main Results:

• Mortality occurred in 9% of patients, with lower body weight and larger shunt size/kg body weight identified as significant risk factors.
• Acute shunt thrombosis occurred in 9% of cases, without mortality. Cardiac decongestive therapy was associated with univentricular hearts.
• Successful shunt takedown was achieved in 28 patients without late mortality.

Conclusions:

• Modified BT shunt palliation remains an important option for infant cardiac defects, despite its associated morbidity and mortality.
• Over-shunting and acute shunt thrombosis are significant challenges in modified BT shunt therapy.
• Effective management strategies are needed to mitigate risks associated with shunt palliation.